| Literature DB >> 35696228 |
Nontokozo Z Msomi1, Ochuko L Erukainure2, Md Shahidul Islam1.
Abstract
The major goals in the management of diabetes are to maintain optimum control of high blood glucose level or hyperglycemia. Dietary modification is one of the most recommended treatment modalities for diabetic patients. The use of foods sweetened with sugar alcohols (also known as polyols) such as xylitol, sorbitol, mannitol, maltitol, lactitol, isomalt and erythritol has brought an escalating interest in the recent years since some sugar alcohols do not rise plasma glucose, as they are partially digested and metabolised. Diet composition and adequacy may be altered by replacing carbohydrates with sugar alcohols. It has been established that these polyols are appropriate sugar substitutes for a healthy lifestyle and diabetic foods. The present review focuses on the evidence supporting the use of sugar alcohols in the management of diabetes, by evaluating their physical and chemical properties, metabolism, absorption, glycemic and insulinemic responses. Although documentation on the glycaemic and insulinemic response of polyols is evident that these compounds have beneficial effects on the better management of hyperglycemia, the possible side effects associated with their normal or higher dosages warned their use according to the relevant Food & Drug Administration guidelines. For the same reason, future studies should also focus on the possible toxicity and side effects associated with the consumption of sugar alcohols in order to define their safety.Entities:
Mesh:
Substances:
Year: 2021 PMID: 35696228 PMCID: PMC9261844 DOI: 10.38212/2224-6614.3107
Source DB: PubMed Journal: J Food Drug Anal Impact factor: 6.157
Fig. 1Chemical structure of commonly used sugar alcohols.
Chemical and physical characteristics of Sugar Alcohols [Adapted from Refs. [9,37,49].
| Sugar alcohol | Molecular weight | Melting point (°C) | Heat of solution | Viscosity at 25 °C | Hygroscopicity |
|---|---|---|---|---|---|
| Xylitol | 152.15 | 94 | −36 | Very low | Medium |
| Sorbitol | 182.17 | 97 | −26 | Medium | High |
| Mannitol | 182.172 | 165 | −29 | Low | Low |
| Maltitol | 344.313 | 150 | −19 | Medium | Medium |
| Lactitol | 344.313 | 94 | −14 | Very low | Very low |
| Isomalt | 688.62 | 167 | −9 | High | Low |
| Erythritol | 122.12 | 121 | −43 | Very low | Very low |
Relative sweetness of sugar alcohols compared to sucrose [Adapted from Ref. [9]].
| Sugar alcohol | Sweetness (Sucrose = 1) |
|---|---|
| Xylitol | 1.0 |
| Sorbitol | 0.5–0.7 |
| Mannitol | 0.5–0.7 |
| Maltitol | 0.9 |
| Lactitol | 0.3–0.4 |
| Isomalt | 0.45–0.65 |
| Erythritol | 0.6–0.8 |
Caloric values of sugar alcohols [Adapted from Refs. [35,47]].
| Sugar alcohols | Caloric value (kcal/g) | |||
|---|---|---|---|---|
|
| ||||
| Europe | Japan | America | Mean caloric value | |
| Xylitol | 2.4 | 3 | 2.4 | 2.6 |
| Sorbitol | 2.4 | 3 | 2.6 | 2.7 |
| Mannitol | 2.4 | 2 | 1.6 | 2 |
| Maltitol | 2.4 | 2 | 2.1 | 2.1 |
| Lactitol | 2.4 | 2 | 2 | 2.1 |
| Isomalt | 2.4 | 2 | 2 | 2.1 |
| Erythritol | 0 | 0 | 0 | 0 |
| Sucrose | 4 | 4 | 4 | 4 |
Glycaemic and insulinemic indexes of Sugar Alcohols [Adapted from Refs. [38,49,53]].
| Sugar alcohol | Glycaemic index | Insulinemic index |
|---|---|---|
| Xylitol | 13 | 11 |
| Sorbitol | 9 | 11 |
| Mannitol | 0 | 0 |
| Maltitol | 35 | 27 |
| Lactitol | 6 | 4 |
| Isomalt | 9 | 6 |
| Erythritol | 0 | 2 |
| Sucrose | 69 | 48 |
Effects of sugar alcohols on diabetic parameters.
| Disease model | Treatment | Duration | Mechanisms of action | References |
|---|---|---|---|---|
| Type 2 diabetic rats | 10% xylitol solution (Ad libitum) | 4 weeks |
Diabetic parameters including pancreatic morphology and serum lipids improved Reduction of blood glucose and serum fructosamine | [ |
| Non-diabetic and type 2 diabetic rats | 164.31–2628.99 mM xylitol in vitro. | 2 h |
Inhibited α-amylase and α-glucosidase activities and jejunal glucose absorption. Improved muscle glucose uptake Delayed gastric emptying Reduced blood glucose level | [ |
| Non-obese healthy men | 25 g of xylitol | Single oral dose |
Lower plasma glucose and insulin response compared to glucose | [ |
| Non-diabetic human subjects | 25 or 50 g of sorbitol | Single oral dose |
Did not significantly elevate glucose levels | [ |
| No-diabetic and type 2 diabetic rats | 2.5–20% sorbitol ex vivo. | 2 h |
Inhibited jejunal glucose absorption. Increased muscle glucose uptake Delayed gastric emptying Reduced blood glucose level | [ |
| Non-diabetic rats | Diet containing 20% mannitol | 8 weeks |
Normal glucose metabolism Lower serum insulin response and cholesterol concentrations | [ |
| Non-diabetic human subjects | 50 g of maltitol | Single oral dose |
Lower plasma glucose and insulin response compared to sucrose | [ |
| Non-diabetic and type 2 diabetic human subjects | 30 or 50 g of maltitol |
Lower plasma glucose and insulin response compared to sucrose | [ | |
| Non-obese healthy men | 25 g of lactitol | Single oral dose |
Rise in plasma glucose, insulin and C-peptide concentrations were lower compared to glucose | [ |
| Non-diabetic healthy human subjects | 30 g of isomalt (Daily) | 4 weeks |
Lower postprandial plasma glucose and reduced fructosamine compared to sucrose | [ |
| Non-diabetic and type 2 diabetic rats | 2.5–20% erythritol ex vivo. | 2 h |
Increased muscle glucose uptake Reduced intestinal glucose absorption and gastric emptying | [ |
| Type 2 diabetic rats | 100, 200 or 400 mg of erythritol (Daily) | 10 days |
Decreased serum glucose levels compared to control Reduction of thio-barbituric acid reactive substances, creatinine and 5-hydroxymethylfurfural compared to control | [ |